Human Placentas and the Changing Face of Reproductive Toxicology Testing
Journal Title: Gynecology and Obstetrics Research – Open Journal - Year 2015, Vol 2, Issue 3
Abstract
Pharmaceuticals are in use by 40-98% of pregnant mothers in the developed world, varying by country. There is a significant potential for obstetricians to further maintain medical prescriptions for chronic diseases during pregnancy, provided there is confidence within the pharmaceutical industry on the safety of their products. The safety of medicinal products incurs several socioeconomic challenges, and the protection of maternal and fetal health is a foremost and top priority. Current guidelines for reproductive toxicity testing in rats and rabbits provide the required data for international regulatory bodies, such as the Federal Drug Agency (FDA) and the European Medicines Agency (EMA) and are described by the Organization for Economic Cooperation and Development (OECD). These animal studies include fetal organ anthropometry, but are devoid of much fetal organ functional data, so there is a case for improving animal data quality during reproductive toxicity testing. Human placental models have a real potential to refine, or even replace some animal use in the pharmaceutical industry, by predicting the probability of unfavourable events for fetal growth and development and highlighting additional specific outcome measures to be used in rat and rabbit reproductive toxicology testing.
Authors and Affiliations
Paul Brownbill
Keywords
Related Articles
- EP ID EP553558
- DOI 10.17140/GOROJ-2-e004
- Views 168
- Downloads 0
Endometriosis Research: Need for a Stem-Cell Based Experimental Model
Endometriosis is a complex disease and not a single phenotype can be delineated in available in vitro models. A comparative analysis of pluripotent stem cells in normal endometrium and endometriosis will give an understa...
Bilateral Massive Hematoma of Bartholin Glands after Prolonged Labour: A Case Report
Background: The early postpartum hematoma represents a rare complication which can appear in the early post-partum period. Its formation and development is favoured by the hypervascularization of the genital area during...
Doppler Indices of Uterine, Umbilical and Fetal Middle Cerebral Arteries Before and After Sildenafil Citrate and Transdermal Nitroglycerin in Cases Suffering from Intrauterine Growth Restriction
Introduction Intrauterine growth restriction (IUGR) is a major cause of perinatal morbidity and mortality. Its diagnosis and treatment constitute one of the most important challenges of present day obstetrics. A drug tha...
Metastatic Cervical Carcinoma with High-Risk Human Papillomavirus (HPV) Positive and P16/ Ki-67 Positive in a 28 Year-Old Female That Did Not Meet the Current Screening Guidelines
A case presentation about an individual treated at Oklahoma State University Medical Center with high-grade metastatic squamous cell carcinoma of the cervix that was high-risk HPV and p16/Ki-67 positive. The clinical pre...
Use of the Partogram in the Bamenda Health District, North-West Region, Cameroon: A Cross-Sectional Study
Background: The partogram is an effective instrument in the follow-up of labor. It enables timely diagnoses of abnormalities and helps in decision-making. Objectives: This study was carried out to 1) establish and compa...